Does adding radiation to chemotherapy help esophageal squamous cell carcinoma patients live longer?
For patients with esophageal squamous cell carcinoma (ESCC), doctors often use chemotherapy before surgery to shrink tumors. Adding radiation to this chemotherapy (called chemoradiotherapy) is another option. The key question is whether adding radiation helps patients live longer. Current research shows that while chemoradiotherapy increases the rate of complete tumor disappearance, it does not clearly improve overall survival compared to chemotherapy alone.
What the research says
A 2023 randomized clinical trial compared neoadjuvant chemoradiotherapy (nCRT) to neoadjuvant chemotherapy (nCT) in 264 patients with locally advanced ESCC. After a median follow-up of about 44 months, overall survival was similar between groups: 3-year survival was 64.1% with nCRT versus 54.9% with nCT, a difference that was not statistically significant 9. A meta-analysis of nine randomized trials also found that for SCC patients, nCRT led to higher rates of complete tumor response (pathologic complete response) and more patients being able to undergo surgery, but did not significantly improve R0 resection rates (complete removal of cancer) 1. Another trial from 2021 reported that nCRT did not improve 3-year survival compared to nCT, and was associated with more postoperative complications 11. For patients who cannot have surgery, adding radiation to chemotherapy (definitive chemoradiotherapy) is standard and improves survival over radiation alone 10. However, for operable patients, the evidence does not show a clear survival benefit from adding radiation to chemotherapy.
What to ask your doctor
- What are the expected benefits and risks of adding radiation to my chemotherapy before surgery?
- How does the chance of a complete tumor response compare between chemoradiotherapy and chemotherapy alone for my specific cancer stage?
- What are the potential side effects of radiation, and how might they affect my recovery from surgery?
- Are there any ongoing clinical trials comparing these treatments that I might be eligible for?
- Based on my overall health and tumor characteristics, which approach do you recommend and why?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.